{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/266724699"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "In particular, management's expectations regarding Gilenya could be affected by, among other things, unexpected clinical trial results, including unexpected new clinical data and unexpected additional analysis of existing clinical data; unexpected regulatory actions or delays or government regulation generally; competition in general; government, industry and general public pricing pressures; unex" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "prnewswire.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/483420168"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/266724699" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/161279594"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/266724699"] } } }
